Hims & Hers Health (NYSE:HIMS) reported quarterly earnings results on February 23, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.08, beating the consensus estimate of $0.03 by $0.05 per share. Revenue came in at $617.8M, missing the estimate of $618.0M.
Hims & Hers Health's stock moved following the earnings release. The stock currently trades at $14.13 with a market capitalization of $8.3B.


